Drug-induced arrhythmias: a scientific statement from the American Heart Association

JE Tisdale, MK Chung, KB Campbell, M Hammadah… - Circulation, 2020 - Am Heart Assoc
Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous
antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as …

Mouse models of atherosclerosis: a historical perspective and recent advances

YT Lee, HY Lin, YWF Chan, KHC Li, OTL To… - Lipids in health and …, 2017 - Springer
Atherosclerosis represents a significant cause of morbidity and mortality in both the
developed and developing countries. Animal models of atherosclerosis have served as …

The Tpeak− Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis

G Tse, M Gong, WT Wong, S Georgopoulos, KP Letsas… - Heart Rhythm, 2017 - Elsevier
Background The T peak− T end interval (the interval from the peak to the end of the T wave),
an electrocardiographic marker reflecting transmural dispersion of repolarization, has been …

Human engineered heart tissue models for disease modeling and drug discovery

H Tani, S Tohyama - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
The emergence of human induced pluripotent stem cells (hiPSCs) and efficient
differentiation of hiPSC-derived cardiomyocytes (hiPSC-CMs) induced from diseased …

[HTML][HTML] Brugada syndrome: A comprehensive review of pathophysiological mechanisms and risk stratification strategies

KHC Li, S Lee, C Yin, T Liu, T Ngarmukos, G Conte… - IJC Heart & …, 2020 - Elsevier
Brugada syndrome (BrS) is an inherited ion channel channelopathy predisposing to
ventricular arrhythmias and sudden cardiac death. Originally believed to be predominantly …

Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy

G Yu, S Chakrabarti, M Tischenko, AL Chen… - Science Translational …, 2022 - science.org
Brugada syndrome (BrS) is a fatal arrhythmia that causes an estimated 4% of all sudden
death in high-incidence areas. SCN5A encodes cardiac sodium channel NaV1. 5 and …

Diffuse fibrosis and repolarization disorders explain ventricular arrhythmias in Brugada syndrome: a computational study

N Biasi, P Seghetti, A Tognetti - Scientific Reports, 2022 - nature.com
In this work, we reported a computational study to quantitatively determine the individual
contributions of three candidate arrhythmic factors associated with Brugada Syndrome. In …

[HTML][HTML] ST elevation: Differential diagnosis and caveats. A comprehensive review to help distinguish ST elevation myocardial infarction from nonischemic etiologies of …

EC de Bliek - Turkish journal of emergency medicine, 2018 - Elsevier
Prompt diagnosis of acute ST segment elevation myocardial infarction (STEMI) by the initial
ECG is important in order to perform an urgent coronary angiography as soon as possible …

Incorporating latent variables using nonnegative matrix factorization improves risk stratification in Brugada syndrome

G Tse, J Zhou, S Lee, T Liu, G Bazoukis… - Journal of the …, 2020 - Am Heart Assoc
Background A combination of clinical and electrocardiographic risk factors is used for risk
stratification in Brugada syndrome. In this study, we tested the hypothesis that the …

The emergence of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a platform to model arrhythmogenic diseases

M Pourrier, D Fedida - International journal of molecular sciences, 2020 - mdpi.com
There is a need for improved in vitro models of inherited cardiac diseases to better
understand basic cellular and molecular mechanisms and advance drug development. Most …